Cargando…

In-Hospital Outcomes and Recurrence of Infectious Spondylitis in Patients with and without Chronic Hemodialysis: A Nationwide Cohort Study

PURPOSE: The incidence of bloodstream infection among end-stage kidney disease (ESKD) patients on chronic hemodialysis (HD) was 26-fold higher than population controls, causing higher morbidity and costs. The aim of this investigation was to clarify the prognostic factors, in-hospital outcomes and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yueh-An, Chen, Chao-Yu, Kuo, George, Yen, Chieh-Li, Tian, Ya-Chung, Hsu, Hsiang-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932927/
https://www.ncbi.nlm.nih.gov/pubmed/35308570
http://dx.doi.org/10.2147/IJGM.S348431
_version_ 1784671538090344448
author Lu, Yueh-An
Chen, Chao-Yu
Kuo, George
Yen, Chieh-Li
Tian, Ya-Chung
Hsu, Hsiang-Hao
author_facet Lu, Yueh-An
Chen, Chao-Yu
Kuo, George
Yen, Chieh-Li
Tian, Ya-Chung
Hsu, Hsiang-Hao
author_sort Lu, Yueh-An
collection PubMed
description PURPOSE: The incidence of bloodstream infection among end-stage kidney disease (ESKD) patients on chronic hemodialysis (HD) was 26-fold higher than population controls, causing higher morbidity and costs. The aim of this investigation was to clarify the prognostic factors, in-hospital outcomes and recurrence of infectious spondylitis of patients with and without chronic HD. PATIENTS AND METHODS: This nationwide study analyzed 2592 patients who admitted for first-time infectious spondylitis between January 1, 2003, and December 31, 2015. Patients were classified into the chronic HD or the non-HD group. The logistic regression model and the general linear model were utilized to determine the impact of chronic HD on in-hospital mortality and recurrence. The Cox proportional hazard model was used to estimate the predictive factors of in-hospital mortality and recurrence. RESULTS: Compared to the non-HD group, patients in the chronic HD group had a higher risk of respiratory failure, sepsis, in-hospital mortality, longer hospital stay, and higher medical spending. Chronic HD was an independent risk factor for in-hospital mortality (hazard ratio 2.21, 95% confidence interval 1.34–3.65, p=0.0019), but not for recurrence. Intravascular device implantation or revision was a prognosticator for the mortality of both groups and a predictor for recurrence of the non-HD group. Surgical treatment was associated with a decreased risk of recurrence, whereas treatment with CT-guided abscess drainage was associated with an increased risk of recurrence in both groups. CONCLUSION: Patients with infectious spondylitis who were receiving chronic HD had a higher in-hospital mortality compared to those without HD. Intravascular device implantations or revision within 6 months was a significant predictor of in-hospital mortality and disease recurrence. Surgical treatment of infectious spondylitis had a lower risk of recurrence than those with CT-guided abscess drainage in both patient groups.
format Online
Article
Text
id pubmed-8932927
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-89329272022-03-19 In-Hospital Outcomes and Recurrence of Infectious Spondylitis in Patients with and without Chronic Hemodialysis: A Nationwide Cohort Study Lu, Yueh-An Chen, Chao-Yu Kuo, George Yen, Chieh-Li Tian, Ya-Chung Hsu, Hsiang-Hao Int J Gen Med Original Research PURPOSE: The incidence of bloodstream infection among end-stage kidney disease (ESKD) patients on chronic hemodialysis (HD) was 26-fold higher than population controls, causing higher morbidity and costs. The aim of this investigation was to clarify the prognostic factors, in-hospital outcomes and recurrence of infectious spondylitis of patients with and without chronic HD. PATIENTS AND METHODS: This nationwide study analyzed 2592 patients who admitted for first-time infectious spondylitis between January 1, 2003, and December 31, 2015. Patients were classified into the chronic HD or the non-HD group. The logistic regression model and the general linear model were utilized to determine the impact of chronic HD on in-hospital mortality and recurrence. The Cox proportional hazard model was used to estimate the predictive factors of in-hospital mortality and recurrence. RESULTS: Compared to the non-HD group, patients in the chronic HD group had a higher risk of respiratory failure, sepsis, in-hospital mortality, longer hospital stay, and higher medical spending. Chronic HD was an independent risk factor for in-hospital mortality (hazard ratio 2.21, 95% confidence interval 1.34–3.65, p=0.0019), but not for recurrence. Intravascular device implantation or revision was a prognosticator for the mortality of both groups and a predictor for recurrence of the non-HD group. Surgical treatment was associated with a decreased risk of recurrence, whereas treatment with CT-guided abscess drainage was associated with an increased risk of recurrence in both groups. CONCLUSION: Patients with infectious spondylitis who were receiving chronic HD had a higher in-hospital mortality compared to those without HD. Intravascular device implantations or revision within 6 months was a significant predictor of in-hospital mortality and disease recurrence. Surgical treatment of infectious spondylitis had a lower risk of recurrence than those with CT-guided abscess drainage in both patient groups. Dove 2022-03-14 /pmc/articles/PMC8932927/ /pubmed/35308570 http://dx.doi.org/10.2147/IJGM.S348431 Text en © 2022 Lu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lu, Yueh-An
Chen, Chao-Yu
Kuo, George
Yen, Chieh-Li
Tian, Ya-Chung
Hsu, Hsiang-Hao
In-Hospital Outcomes and Recurrence of Infectious Spondylitis in Patients with and without Chronic Hemodialysis: A Nationwide Cohort Study
title In-Hospital Outcomes and Recurrence of Infectious Spondylitis in Patients with and without Chronic Hemodialysis: A Nationwide Cohort Study
title_full In-Hospital Outcomes and Recurrence of Infectious Spondylitis in Patients with and without Chronic Hemodialysis: A Nationwide Cohort Study
title_fullStr In-Hospital Outcomes and Recurrence of Infectious Spondylitis in Patients with and without Chronic Hemodialysis: A Nationwide Cohort Study
title_full_unstemmed In-Hospital Outcomes and Recurrence of Infectious Spondylitis in Patients with and without Chronic Hemodialysis: A Nationwide Cohort Study
title_short In-Hospital Outcomes and Recurrence of Infectious Spondylitis in Patients with and without Chronic Hemodialysis: A Nationwide Cohort Study
title_sort in-hospital outcomes and recurrence of infectious spondylitis in patients with and without chronic hemodialysis: a nationwide cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932927/
https://www.ncbi.nlm.nih.gov/pubmed/35308570
http://dx.doi.org/10.2147/IJGM.S348431
work_keys_str_mv AT luyuehan inhospitaloutcomesandrecurrenceofinfectiousspondylitisinpatientswithandwithoutchronichemodialysisanationwidecohortstudy
AT chenchaoyu inhospitaloutcomesandrecurrenceofinfectiousspondylitisinpatientswithandwithoutchronichemodialysisanationwidecohortstudy
AT kuogeorge inhospitaloutcomesandrecurrenceofinfectiousspondylitisinpatientswithandwithoutchronichemodialysisanationwidecohortstudy
AT yenchiehli inhospitaloutcomesandrecurrenceofinfectiousspondylitisinpatientswithandwithoutchronichemodialysisanationwidecohortstudy
AT tianyachung inhospitaloutcomesandrecurrenceofinfectiousspondylitisinpatientswithandwithoutchronichemodialysisanationwidecohortstudy
AT hsuhsianghao inhospitaloutcomesandrecurrenceofinfectiousspondylitisinpatientswithandwithoutchronichemodialysisanationwidecohortstudy